RENAL-FUNCTION OF HYPERTENSIVE PATIENTS WITH RENAL-FAILURE UNDER TREATMENT WITH THE DUAL ELIMINATED ACE-INHIBITOR SPIRAPRIL

被引:0
|
作者
HAUFE, CC
SIERAKOWSKI, B
JANSA, U
STEIN, G
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients and Method: Spirapril is a recent ACE inhibitor with a both renal and hepatic elimination pathway. In order to determine its tolerability, primarily the impact on renal function, Spirapril was tested in a single-blind trial with a 2-week placebo run-in phase and a 4-week active treatment period. Forty-nine patients (34 males and 15 females) with varying degrees of renal impairment were included. Their pretreatment diastolic blood pressure (DBP) ranged from 95 to 115 mm Hg. Spirapril was administered in oral doses of 6 mg once daily. Results: Forty-four patients completed the study. Four patients dropped out due to side effects, 1 patient was withdrawn from the study due to lack of antihypertensive efficacy. 48% of the completers with renal failure achieved a normalized diastolic blood pressure (DBP less-than-or-equal-to 90 mm Hg) or a reduction in DBP of greater-than-or-equal-to 10 mm Hg; the corresponding figure for patients with normal renal function was 31%. Renal function was assessed in the beginning and at the end of the active Spirapril treatment period using Tc-99m-DTPA-clearance (representing glomerular filtration rate), J-131-hippuran-clearance (representing renal plasma flow) and creatinine clearance. Particularly in patients with renal impairment, Spirapril did not deteriorate renal function as given by these parameters. Regression analysis revealed a linear correlation between total plasma clearance of the active metabolite Spiraprilate and creatinine clearance. There was no evidence for drug accumulation. Conclusion: In patients with renal impairment the pharmacokinetic results indicate a non-renal elimination of the drug. Spirapril 6 mg once daily is concluded to be a well tolerated antihypertensive therapy for patients with mild to moderate hypertension and varying degrees of chronic renal failure.
引用
收藏
页码:416 / 420
页数:5
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF THE NOVEL LONGACTING ACE INHIBITOR RAMIPRIL IN PATIENTS WITH RENAL-FAILURE
    AURELL, M
    DELIN, K
    HERLITZ, H
    LJUNGMAN, S
    WITTE, P
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 241 - 241
  • [22] REGRESSION OF RENAL DAMAGE IN HYPERTENSIVE PATIENTS WITH RENAL-FAILURE
    RUILOPE, LM
    MEDICINA CLINICA, 1988, 90 (04): : 162 - 163
  • [23] ACE-INHIBITOR TREATMENT OF CHRONIC-RENAL-FAILURE IN A CANINE MODEL OF HEREDITARY NEPHRITIS
    GAINS, M
    GRODECKI, K
    JACOBS, R
    BAUMAL, R
    VALLI, V
    THORNER, P
    OSMOND, D
    COTTER, B
    LABORATORY INVESTIGATION, 1995, 72 (01) : A159 - A159
  • [24] RENAL-FUNCTION AND RENAL METABOLISM DURING THE RECOVERY PHASE OF ACUTE RENAL-FAILURE
    PAREKH, N
    VEITH, U
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1979, 379 : R15 - R15
  • [25] PHARMACOKINETICS OF FLECAINIDE IN PATIENTS WITH MILD AND MODERATE RENAL-FAILURE COMPARED WITH PATIENTS WITH NORMAL RENAL-FUNCTION
    BRAUN, J
    KOLLERT, JR
    BECKER, JU
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 31 (06) : 711 - 714
  • [26] COMPARISON OF ONSET AND DURATION OF ACTION OF VECURONIUM IN PATIENTS WITH NORMAL RENAL-FUNCTION AND RENAL-FAILURE PATIENTS
    MUNSHI, CA
    ARFMAN, RC
    GANDHI, S
    ANESTHESIOLOGY, 1993, 79 (3A) : A358 - A358
  • [27] RENAL-FUNCTION IN SPONTANEOUSLY HYPERTENSIVE RATS UNDER MINOXIDIL TREATMENT
    HAGEMANN, I
    SU, LM
    STRANGFELD, D
    PIETSCH, R
    KRUSE, I
    SCHURER, M
    SIEWERT, H
    MORITZ, V
    MASSOW, S
    SCHOLZE, J
    BIOMEDICA BIOCHIMICA ACTA, 1987, 46 (06) : 505 - 515
  • [28] THE PHARMACODYNAMICS AND PHARMACOKINETICS OF VECURONIUM IN PATIENTS ANESTHETIZED WITH ISOFLURANE WITH NORMAL RENAL-FUNCTION OR WITH RENAL-FAILURE
    LYNAM, DP
    CRONNELLY, R
    CASTAGNOLI, KP
    CANFELL, PC
    CALDWELL, J
    ARDEN, J
    MILLER, RD
    ANESTHESIOLOGY, 1988, 69 (02) : 227 - 231
  • [29] ACE INHIBITORS - ANTIHYPERTENSIVE TREATMENT AND RENAL-FUNCTION
    CAMPANACCI, L
    BELLINI, G
    COSENZI, A
    FRANCA, G
    PIEMONTESI, A
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1989, 15 (11-12) : 591 - 597
  • [30] THE EFFECT OF CONTRAST UPON RENAL-FUNCTION IN ACUTE RENAL-FAILURE IN THE RAT
    NEWHOUSE, JH
    AMIS, ES
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1988, 151 (01) : 206 - 206